News

Find News

Filter articles

Applied Filters

Showing 631 to 640 of 642 results

European Commission targets alleged ‘pay-for-delay’ with pharma fines

EU20-06-2013

The European Commission’s competition directorate has levied fines totalling €146 million ($195 million) against originator pharmaceutical company Lundbeck and several producers of generics drugs.

Hi-tech and life sciences dominate at EPO awards

EU29-05-2013

The inventor of the world’s first flat-panel liquid crystal display, Martin Schadt, was among a number of winners at the European Patent Office European Inventor Award 2013.

Actavis to buy Warner Chilcott

Ireland, US22-05-2013

Actavis announced on May 20 it will acquire specialty pharmaceutical company Warner Chilcott plc in a deal worth an estimated $5 billion.

Ideas Matter: the importance of IP in the fight against cancer

UK20-05-2013

On May 14, healthcare experts met in London to share and discuss developments in cancer detection, prevention, treatment and maintenance, and how IP protection and management are vital in attracting investment.

Ideas Matter: Philips and Microsoft in life sciences

UK20-05-2013

At the Ideas Matter roundtable last week LSIPR spoke to Maaike van Velzen, general manager of Philips Group Innovation’s IP and Standards division, about the importance of using IP to promote the company’s vision.

AstraZeneca loses Seroquel appeal

UK10-05-2013

The UK Court of Appeal has upheld the High Court’s decision that AstraZeneca’s patent for a sustained release formulation of anti-psychotic drug quetiapine is invalid.

Orchid invests in new European pharma

France, Germany, India25-04-2013

Indian pharmaceutical company Orchid Chemicals and Pharmaceuticals has entered into a partnership with new European biopharmaceutical company Allecra Therapeutics.

OFT accuses GSK of market abuse over pay-for-delay deals

UK19-04-2013

The UK Office of Fair Trading has accused GlaxoSmithKline of abusing its market dominance and infringing UK competition law by paying rivals to delay releasing generic versions of its anti-depressant Seroxat.

1st Annual Life Sciences Law Forum: what do we know about the Unitary Patent?

06-03-2013

Day two of the 1st Annual Life Sciences Forum in London saw panellists discuss the European Unitary Patent and the Unified Patent Court.

India rejects Bayer plea over compulsory licence

04-03-2013

India’s patent authorities have dealt a blow to German pharma company Bayer by refusing to overturn an order forcing the company to license one of its patented drugs.

Showing 631 to 640 of 642 results

LSIPR